{"SPADE_UN_28802": {"basic": {"SPADE ID": "SPADE_UN_28802", "Peptide Name": "Cathelicidin-6, BMAP-27(1-18), Myeloid antibacterial peptide 27(1-18)", "Sequence": "GRFKRFRKKFKKLFKKLS", "Source": "", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Target Organism": "Escherichia coli ATCC 25922(MIC=2µM),Escherichia coli ML-35(MIC=4µM),Escherichia coli D21(MIC=4µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MIC=4µM),Serratia marcescens ATCC 8100(MIC=2µM),Staphylococcus aureus ATCC 25923(MIC=2µM),Staphylococcus aureus Cowan 1(MIC=2µM),Staphylococcus aureus(MIC=4µM),Staphylococcus epidermidis ATCC 12228(MIC=1µM),Bacillus megaterium Bm11(MIC=2µM),Candida albicans(MIC=16µM),Cryptococcus neoformans(MIC=4µM),Escherichia coli KCTC 1682(MIC=4µM),Pseudomonas aeruginosa KCTC 1637(MIC=4µM),Salmonella typhimurium KCTC 1926(MIC=2µM),Bacillus subtilis KCTC 3068(MIC=4µM),Staphylococcus epidermidis KCTC 1917(MIC=4µM),Staphylococcus aureus KCTC 1621(MIC=4µM),Enterococcus faecium(MIC=8–>32µM),Streptococcus agalactiae(MIC=1–4µM),Serratia marcescens(MIC=4–>32µM),Escherichia coli O18:K1:H7 Bort(MIC=8µM),Staphylococcus aureus(MIC=4–8µM),Staphylococcus aureus KCTC 1621(MIC=2-4µM),Escherichia coli KCTC 1682(MIC=2-4µM),Human breast adenocarcinoma MDA-MB-361(50-60% Cytotoxicity=>100µM),Human lung carcinoma A549(50-60% Cytotoxicity=>100µM),Staphylococcus epidermidis ATCC 35984(MIC=2µM),Staphylococcus aureus ATCC 25923(MIC=4µM),Pseudomonas aeruginosa ATCC 27853(MIC=2µM)", "Sequence Length": 18}, "extended_data_url": "SPADE_UN_28802_extended.json"}}